Debon Herbals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-07-2024
- Paid Up Capital ₹ 1.00 M
as on 04-07-2024
- Company Age 29 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.05 Cr
as on 04-07-2024
- Revenue -63.11%
(FY 2022)
- Profit -1970.44%
(FY 2022)
- Ebitda -90.77%
(FY 2022)
- Net Worth -416.77%
(FY 2022)
- Total Assets -17.05%
(FY 2022)
About Debon Herbals
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.05 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kajal Anand, Shyam Anand, and Rishi Anand serve as directors at the Company.
- CIN/LLPIN
U24246MH1995PTC091205
- Company No.
091205
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jul 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Debon Herbals Private Limited offer?
Debon Herbals Private Limited offers a wide range of products and services, including Herbal Skin Care Cosmetics, Herbal Cream, Natural Cosmetics, Neem Face Pack, Skin Care Cosmetics, Astringent Lotion, Ayurvedic, Herbal Oils and Cosmetics, Herbal Cosmetics, Cosmetics, Hair & Beauty Products, Herbal Body Care Cosmetics.
Who are the key members and board of directors at Debon Herbals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Anand  | Director | 01-Sep-2017 | Current |
| Kajal Anand | Director | 27-Jan-2022 | Current |
| Rishi Anand | Director | 22-Jan-2015 | Current |
Financial Performance of Debon Herbals.
Debon Herbals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 63.11% decrease. The company also saw a substantial fall in profitability, with a 1970.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 416.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Debon Herbals?
In 2020, Debon Herbals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 12 Feb 2015 | ₹8.70 M | Satisfied |
The Saraswat Co-Op Bank Ltd Creation Date: 17 Apr 2008 | ₹0.30 M | Satisfied |
The Saraswat Co-Operative Bank Ltd Creation Date: 08 Nov 2005 | ₹1.50 M | Satisfied |
How Many Employees Work at Debon Herbals?
Unlock and access historical data on people associated with Debon Herbals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Debon Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Debon Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
